ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2204

Early Treatment With Methotrexate Is Associated With Extensive Re-Ordering Of The Neutrophil Transcriptome In Juvenile Idiopathic Arthritis

Zihua Hu1, Kaiyu Jiang2, Mark B. Frank3, Yanmin Chen2 and James N. Jarvis2, 1Center for Computational Research, University at Buffalo, Buffalo, NY, 2Pediatrics, The University at Buffalo, Buffalo, NY, 3Arthritis & Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Gene Expression, Genomics and juvenile idiopathic arthritis (JIA)

  • Tweet
  • Email
  • Print
Session Information

Title: Pediatric Rheumatology - Pathogenesis and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose: We have previously demonstrated a role for neutrophils in polyarticulartar juvenile idiopathic arthritis (JIA) disease pathogenesis. For example, JIA neutrophils show specific abnormalities in gene expression that do not correct when children reach remission. The studies here were intended to gain insights into mechanisms of therapeutic response in JIA by examining molecular events in neutrophils early in therapy  

Methods: We examined 35 children with JIA who had active, untreated disease (ADU) and 26 children with active disease (ADM) who had been on therapy with methotrexate (MTX) for periods ranging from 2 weeks to 2 months.  We also studied 15 healthy control children (HC) for comparison.  We performed transcriptome analysis using Affymetrix exon and miRNA hybridization-based microarrays. Exon gene expression data were processed using RMA software in the Affy package of Bioconductor and analyzed using t-tests to detect differentially expressed genes (DEGs) between JIA and HC as well as between ADM individuals and healthy controls. Enrichment analyses to determine the associated functions for DEGs were performedd using by DAVID Functional Annotation Tools (http://david.abcc.ncifcrf.gov/).

Results: 216 genes were detected showing differential expression between JIA and HC.  More than half of these genes (51%) are involved in regulating gene/exon splicing. Treatment with MTX was found to have substantial impact on JIA transcriptome, even while children still maintained active disease status. Of the 216 genes that were differentially expressed between HC and ADU, 112 of them (52%) reverted to normal expression levels.  However, early treatment with MTX was associated with extensive re-ordering of the neutrophil transcriptome, as shown by the large number of DEGs.  A total of 1271 DEGs were detected between ADM and HC, of which 1167 (92%) are unique to ADM when compared to ADU.  These DEGs are associated with a broad range of functions, including more than 20 biological processes and 40 gene groups. Similar results were obtained from both isoform-level and miRNA  expression data analysis. While 193 and 73 differentially expressed miRNAs were detected in ADM and ADU, respectively, 53 of them are common to both groups (p = 1.3E-22).  At  the isoform level, we found 2808 isoforms from ADM and 446 isoforms from ADU displaying differential exon splicing, 275 of them are common to both groups (p < 6.5E-322).  Functional analysis indicated that the 446 isoforms were associated with pathways of spliceosome, apoptosis, endocytosis, B and T cell receptor signaling pathways.  On the other hand, the 275 common isoforms display enrichment in the pathways of spliceosome and endocytosis.

Conclusion: Upon initiation of therapy with methotrexate, substantial re-ordering of the neutrophil transcriptome occurs.  How these changes relate to eventual therapeutic response, and whether and how they relate to or lead to changes in adaptive immune function are ongoing areas of investigation in our research groups.


Disclosure:

Z. Hu,
None;

K. Jiang,
None;

M. B. Frank,
None;

Y. Chen,
None;

J. N. Jarvis,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/early-treatment-with-methotrexate-is-associated-with-extensive-re-ordering-of-the-neutrophil-transcriptome-in-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology